U.S. Markets close in 5 hrs 17 mins

NovoCure Limited (NVCR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
68.94+1.76 (+2.62%)
As of 04:00PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close67.18
Bid67.00 x 800
Ask70.01 x 1200
Day's Range62.91 - 69.11
52 Week Range60.57 - 232.76
Avg. Volume739,450
Market Cap7.39B
Beta (5Y Monthly)0.96
PE Ratio (TTM)N/A
EPS (TTM)-0.27
Earnings DateFeb 23, 2022 - Feb 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est119.33
  • Motley Fool

    Why Novocure Stock Is Jumping Today

    Shares of Novocure Limited (NASDAQ: NVCR) are jumping 12.9% higher as of 11:09 a.m. ET on Thursday. The solid gain came after investment firm Truist Financial upgraded the stock from a hold to a buy recommendation. Truist kept its 12-month price target for the stock at $125, which represents upside potential of more than 70%.


    West Oak Capital, LLC Buys Citigroup Inc, Merck Inc, Vanguard Short-Term Corporate Bond ETF, ...

    Westlake Village, CA, based Investment company West Oak Capital, LLC (Current Portfolio) buys Citigroup Inc, Merck Inc, Vanguard Short-Term Corporate Bond ETF, AmerisourceBergen Corp, Marsh & McLennan Inc, sells ChargePoint Holdings Inc, ChargePoint Holdings Inc, Microchip Technology Inc, Baxter International Inc, Aflac Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, West Oak Capital, LLC.

  • Investor's Business Daily

    Biotech Bloodbath Continues Despite Gene-Editing Deals For Pfizer, Bayer

    The bloodbath continued for biotech stocks Monday despite massive deals for Pfizer and Bayer in gene-editing technology.